US Patent 8097752 Antiprotozoal ring-substituted phospholipids
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 4 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+307 characters)
Article
Patent abstract
Disclosed are novel ring containing phospholipids represented by the structural formula A-X—PO3—W and physiologically acceptable salts thereof and a process for the preparation of these compounds. The compounds can be used for the treatment of protozoal diseases and especially leishmaniasis.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alexandros Makriyannis0
Maria Koufaki0
Nikolaos Avlonitis0
Theodora Calogeropoulou0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08097752 Antiprotozoal ring-substituted phospholipids US Patent 8097752 Antiprotozoal ring-substituted phospholipids
Infobox
Patent Number
08097752
Patent Number
8097752
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08097752 Antiprotozoal ring-substituted phospholipids
Infobox
Is a
Patent jurisdiction
Patent number
08097752
Date of patent
January 17, 2012
Patent application number
10531324
Date Filed
October 29, 2003
Patent primary examiner
Find more entities like US Patent 8097752 Antiprotozoal ring-substituted phospholipids
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.